Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Oral (17-β)-3-oxoandrost-4-en-17-yl tridecanoate therapy

Oral (17-β)-3-oxoandrost-4-en-17-yl tridecanoate therapy

US Patent 12318396 · Granted Jun 3, 2025

Assignee

No assignee recorded.

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Hydroxyprogesterone caproate compositions and methods of use in preventing prete2025
Oral allopregnanolone compositions and methods of use2025
Oral allopregnanolone compositions and methods of use2025
(17-)-3-oxoandrost-4-en-17-yl dodecanoate compositions and methods of preparatio2025
(17-)-3-oxoandrost-4-en-17-yl dodecanoate compositions and methods of preparatio2025
(17-)-3-oxoandrost-4-en-17-yl dodecanoate compositions and methods of preparatio2025
Composition and method for oral delivery of androgen prodrugs2025
Composition and method for oral delivery of androgen prodrugs2025
Oral testosterone therapy2025
Oral testosterone therapy2025
Oral testosterone therapy2025
Testosterone dodecanoate compositions and methods2025